Effect of sugammadex and rocuronium combination on cranial neurotoxicity in rats: experimental study

Sugammadex is frequently used in clinical anesthetic practice. In order to determine whether sugammadex has neurotoxic effect, histopathological evaluation and antioxidant status of brain and cerebellum tissues were investigated. Thirty-two adult sprague dawley rats were divided into four groups. Pu...

Full description

Bibliographic Details
Main Author: Öznur ULUDAĞ
Format: Article
Language:English
Published: Kafkas University, Faculty of Veterinary Medicine 2019-05-01
Series:Kafkas Universitesi Veteriner Fakültesi Dergisi
Subjects:
Online Access:https://vetdergikafkas.org/pdf.php?id=2537
_version_ 1797800692627275776
author Öznur ULUDAĞ
author_facet Öznur ULUDAĞ
author_sort Öznur ULUDAĞ
collection DOAJ
description Sugammadex is frequently used in clinical anesthetic practice. In order to determine whether sugammadex has neurotoxic effect, histopathological evaluation and antioxidant status of brain and cerebellum tissues were investigated. Thirty-two adult sprague dawley rats were divided into four groups. Purine Control Group (Group 1, n=8) had no action. The control group (Group 2, n=8) received 16 mg/kg serum physiologic, the sugammadex group (Group 3, n=8) received 16 mg/kg sugammadex and the sugammadex+rocuronium group (Group 4, n=8) received 16 mg/kg sugammadex and 1 mg/kg rocuronium. After drug administration, brain and cerebellum tissues were evaluated histological and biochemically for and oxidative damage. The overall structure of the brain and cerebellum tissues were normal in all groups. Images of the layers and the neurons contained there in were normal. No pathological findings were found. There had no statistically significant difference between the groups in terms of glutathione enzyme activity levels (GSH-Px) and the malondialdehyde (MDA) levels in rat brain. GSH-Px and MDA levels had a slight increase in sugammadex and sugammadex+rocuronium group in cerebellum tissues. These increases were statistically significant. But this increase did not cause any histopathological damage to the cerebellum tissue. The study demonstrates that sugammadex is safe for reversal of rocuronium effects in rats. Sugammadex in the dose ranges used in the studies, did not produce adverse effects in rats brain and cerebellum tissues.
first_indexed 2024-03-13T04:38:05Z
format Article
id doaj.art-2fb7641c98444a1e8aa67993acaf6c92
institution Directory Open Access Journal
issn 1309-2251
language English
last_indexed 2024-03-13T04:38:05Z
publishDate 2019-05-01
publisher Kafkas University, Faculty of Veterinary Medicine
record_format Article
series Kafkas Universitesi Veteriner Fakültesi Dergisi
spelling doaj.art-2fb7641c98444a1e8aa67993acaf6c922023-06-19T06:34:00ZengKafkas University, Faculty of Veterinary MedicineKafkas Universitesi Veteriner Fakültesi Dergisi1309-22512019-05-0125679379910.9775/kvfd.2019.218852537Effect of sugammadex and rocuronium combination on cranial neurotoxicity in rats: experimental studyÖznur ULUDAĞ0Anesthesiology and Reanimation Department, Adiyaman University Medical School, TR-02100 Adiyaman - TURKEYSugammadex is frequently used in clinical anesthetic practice. In order to determine whether sugammadex has neurotoxic effect, histopathological evaluation and antioxidant status of brain and cerebellum tissues were investigated. Thirty-two adult sprague dawley rats were divided into four groups. Purine Control Group (Group 1, n=8) had no action. The control group (Group 2, n=8) received 16 mg/kg serum physiologic, the sugammadex group (Group 3, n=8) received 16 mg/kg sugammadex and the sugammadex+rocuronium group (Group 4, n=8) received 16 mg/kg sugammadex and 1 mg/kg rocuronium. After drug administration, brain and cerebellum tissues were evaluated histological and biochemically for and oxidative damage. The overall structure of the brain and cerebellum tissues were normal in all groups. Images of the layers and the neurons contained there in were normal. No pathological findings were found. There had no statistically significant difference between the groups in terms of glutathione enzyme activity levels (GSH-Px) and the malondialdehyde (MDA) levels in rat brain. GSH-Px and MDA levels had a slight increase in sugammadex and sugammadex+rocuronium group in cerebellum tissues. These increases were statistically significant. But this increase did not cause any histopathological damage to the cerebellum tissue. The study demonstrates that sugammadex is safe for reversal of rocuronium effects in rats. Sugammadex in the dose ranges used in the studies, did not produce adverse effects in rats brain and cerebellum tissues.https://vetdergikafkas.org/pdf.php?id=2537ratneuromuscular blocksugammadexrocuroniumbrain tissuescerebellum tissuesneurotoxicity
spellingShingle Öznur ULUDAĞ
Effect of sugammadex and rocuronium combination on cranial neurotoxicity in rats: experimental study
Kafkas Universitesi Veteriner Fakültesi Dergisi
rat
neuromuscular block
sugammadex
rocuronium
brain tissues
cerebellum tissues
neurotoxicity
title Effect of sugammadex and rocuronium combination on cranial neurotoxicity in rats: experimental study
title_full Effect of sugammadex and rocuronium combination on cranial neurotoxicity in rats: experimental study
title_fullStr Effect of sugammadex and rocuronium combination on cranial neurotoxicity in rats: experimental study
title_full_unstemmed Effect of sugammadex and rocuronium combination on cranial neurotoxicity in rats: experimental study
title_short Effect of sugammadex and rocuronium combination on cranial neurotoxicity in rats: experimental study
title_sort effect of sugammadex and rocuronium combination on cranial neurotoxicity in rats experimental study
topic rat
neuromuscular block
sugammadex
rocuronium
brain tissues
cerebellum tissues
neurotoxicity
url https://vetdergikafkas.org/pdf.php?id=2537
work_keys_str_mv AT oznuruludag effectofsugammadexandrocuroniumcombinationoncranialneurotoxicityinratsexperimentalstudy